Evidence map›Paper›PMID 38446235›Full record

ReviewArchives of dermatological research2024

Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum.

Sarah L Becker, Jorge A Rios-Duarte, Georgia Mae Morrison, Eric Xia, Arash Mostaghimi, Sonia Himed, Benjamin H Kaffenberger, Donglin Zhang, Bridget E Shields, Anna L Cogen and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Sarah L BeckerDepartment of Dermatology, Oregon Health and Science University, 3303 S Bond Ave Building 1, 16th Floor, Portland, OR, 97239, USA. beckersa@ohsu.edu.
Jorge A Rios-DuarteSchool of Medicine, Universidad de los Andes, Bogotá D.C., Colombia.
Georgia Mae MorrisonDepartment of Dermatology, Oregon Health and Science University, 3303 S Bond Ave Building 1, 16th Floor, Portland, OR, 97239, USA.
Eric XiaDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Arash MostaghimiDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sonia HimedDepartment of Dermatology, The Ohio State University, Columbus, OH, USA.
Benjamin H KaffenbergerDepartment of Dermatology, The Ohio State University, Columbus, OH, USA.
Donglin ZhangUniversity of Wisconsin, Madison, WI, USA.
Bridget E ShieldsUniversity of Wisconsin, Madison, WI, USA.
Anna L CogenUniversity of Washington, Seattle, WA, USA.
Alex G Ortega-LoayzaDepartment of Dermatology, Oregon Health and Science University, 3303 S Bond Ave Building 1, 16th Floor, Portland, OR, 97239, USA.
Oregon Health & Science University · USThe Ohio State University · USUniversity of Wisconsin–Madison · USBrigham and Women's Hospital · USHarvard University · USUniversidad de Los Andes · COUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peristomal pyoderma gangrenosum is an uncommon subtype of pyoderma gangrenosum mainly affecting stoma sites of patients with inflammatory bowel disease. While surgical treatments are often used to assist healing, little is known about the relationship between surgical interventions and the rate of recurrence of peristomal pyoderma gangrenosum. The aim of this study was to identify patient and clinical factors associated with peristomal pyoderma gangrenosum recurrence following surgical intervention. A multi-institutional retrospective case series and literature review was conducted to evaluate patient characteristics and perioperative treatment. Patients of any age with peristomal pyoderma gangrenosum undergoing surgical operations related to their pyoderma gangrenosum or due to another comorbidity were included. Descriptive statistics were used to characterize demographic information. Associations were evaluated using Wilcoxon's rank-sum test for continuous variables and Fisher's exact test for categorical data. Thirty-seven cases were included, 78.3% of which had a history of inflammatory bowel disease. Overall, 13 (35.1%) cases experienced recurrence at 30 days. There was no significant association identified between patient demographics, stoma location, surgical intervention, or perioperative treatment with rate of recurrence at 30 days post-operation. While no clinical risk factors or treatments were associated with recurrence, our work underscores the importance of a multidisciplinary approach to this disease to address gastrointestinal, dermatologic, and surgical components of treatment.

Indexed as

Inflammatory Bowel DiseasesPyoderma GangrenosumHumansPostoperative PeriodRetrospective StudiesRisk FactorsIrritable bowel diseasePerioperative outcomesPeristomal pyoderma gangrenosum

Identifiers

PMID38446235
OpenAlexW4392509705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.